Supporting health research to improve health outcomes globally
Creating equity and reducing health disparities everywhere
CUGH Board Member, Dr. Philip Landrigan, co-authored an opinion piece with Dr. Lynn R. Goldman that was recently featured in the NYTimes, "A Bad Move That Could End Up Exposing Kids to Chemicals: Without explaining why, the E.P.A. has sidelined its top children’s health advocate." Click here to access the piece or click on the PDF version in the attachment below.
Global Health Competencies are central to Global Health education at undergraduate and graduate levels. The CUGH Competencies Toolkit is an essential resource for educators - including over 1000 multimedia teaching objects to use inside and outside the classroom, assisting faculty to nurture Global Health knowledge, skills and attitudes.
Join this webinar to learn more about how CUGH can assist faculty in all disciplines approaching Global Health to further the perspectives of learners and fellow faculty.
One of the most important things you can do as a US citizen is to register and vote. On November 6, 2018 vote for candidates who support addressing the global health challenges we face, both international and domestic. See how to register and vote here. Remind your family and friends to do so, too. See how you can vote here and share our 'Get Out And Vote' flyer below.
In our efforts at CUGH to reduce our environmental footprint, we will share opportunities on ways we can all do this. Please see the list of airlines that offer carbon offsets when flying with them and other resources for reducing your carbon footprint in the attachments section below.
A new documentary film by AIDS-Free World: The drugs Bedaquiline and Delamanid can mean the difference between life and death for people suffering from the worst and most noxious strain of tuberculosis in the world, MDR-TB. The government of India has restricted access to the drugs for its 140,000 MDR-TB sufferers. South Africa has made a different choice for 20,000 MDR-TB patients. The consequences are profound.
Low- and middle-income countries (LMICs) face a range of obstacles in healthcare including access, funding, education, and personnel. However, laboratory diagnostics including pathology are particularly challenging because of the specialized personnel, unique reagents, quality processes, and overall logistics of delivering the right diagnosis to the right patient at the right time.
